8-K: USANA Health Sciences Reports Mixed Q1 Results, China Sales Surge Offsets Weakness in Other Markets

USANA Health Sciences reported a decrease in first-quarter net sales and diluted EPS compared to the previous year, but saw growth in China which helped offset declines in other regions.

Summary

• USANA Health Sciences reported first-quarter net sales of $228 million, an 8% decrease compared to $248 million in the same quarter of the previous year.
• Diluted earnings per share (EPS) for the first quarter were $0.86, down from $0.95 in the first quarter of 2023.
• However, net sales increased by 2% sequentially in constant currency.
• The company's performance was driven by a successful sales incentive in mainland China, which saw a 15% year-over-year increase in active customers.
• Despite the strong performance in China, other key markets did not meet internal expectations due to ongoing inflationary pressures and price sensitivity among consumers.
• The company generated $18 million in operating cash flow during the quarter and ended with $328 million in cash and cash equivalents.
• USANA repurchased 194,000 shares for $9 million during the quarter and has $62 million remaining under the current share repurchase authorization.
• The company is reiterating its fiscal year 2024 net sales outlook of $850 million to $920 million and diluted EPS outlook of $2.40 to $3.00.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While there are positives such as strong performance in China and a healthy balance sheet, the overall results show a decline in sales and earnings, and the company faces significant challenges in other key markets. The reiteration of the full-year outlook provides some reassurance, but the expected slowdown in Q2 tempers optimism.

Positives

• The company experienced a 15% year-over-year increase in active customers in mainland China.
• Net sales in mainland China increased by 3% year-over-year and 10% sequentially.
• The company's gross margin increased by 60 basis points to 81.1% of net sales.
• USANA generated $18 million in operating cash flow during the quarter.
• The company maintains a strong cash position with $328 million in cash and cash equivalents.
• The company is actively engaging with Associate leaders through events and training.
• The company completed its first full quarter of operations in India and is optimistic about its long-term growth potential.

Negatives

• First quarter net sales decreased by 8% year-over-year.
• Diluted EPS decreased by 9% year-over-year.
• Sales in North Asia decreased by 28% year-over-year.
• Sales in Southeast Asia Pacific decreased by 22% year-over-year.
• Sales in the Americas and Europe region decreased by 12% year-over-year.
• The company experienced a challenging operating environment due to inflationary pressures and price sensitivity among consumers in many markets.
• The effective tax rate increased to 39.0% from 35.5% in the first quarter of 2023.

Risks

• The company faces risks related to global economic conditions, including continued inflationary pressures.
• There is a reliance on the network of independent Associates.
• The company is subject to governmental regulation of its products and direct selling business model.
• Deteriorating foreign and trade relations could negatively impact the business.
• Geopolitical conflicts and compliance with data privacy laws pose risks.
• Material breaches of information technology systems and adverse publicity could negatively affect the company.
• Fluctuations in currency exchange rates and the potential for a resurgence of COVID-19 are also risks.

Future Outlook

The company is reiterating its fiscal year 2024 net sales outlook of $850 million to $920 million and diluted EPS outlook of $2.40 to $3.00. The company expects lower sequential results in the second quarter due to a slowdown in promotional activity, particularly in mainland China.

Management Comments

• Our top line results during the first quarter were driven by a successful sales incentive in mainland China, which helped counter the seasonal slowdown that we experience during the Lunar New Year holiday, said Jim Brown, President and Chief Executive Officer.
• Strength in our mainland China operations carried our first quarter results, said Doug Hekking, Chief Financial Officer.
• We remain committed to engaging with Associate leaders throughout each of our markets and plan to offer additional market-specific incentives throughout the year to improve sales and customer activity levels, said Doug Hekking, Chief Financial Officer.
• We remain committed to our strategies and are confident in the long-term prospects for our business, said Jim Brown, President and CEO.

Industry Context

The direct selling industry is facing challenges due to global economic conditions and inflationary pressures, which are impacting consumer spending. USANA's results reflect these broader trends, with strong performance in China contrasting with weakness in other markets. The company's focus on engaging with Associate leaders and offering market-specific incentives is a common strategy in the industry to drive sales and customer growth.

Comparison to Industry Standards

• USANA's performance in China, with a 15% increase in active customers, is a positive outlier compared to other direct selling companies that have struggled in the region.
• The decline in sales in other regions, particularly North Asia and Southeast Asia Pacific, is consistent with the challenges faced by many companies in the direct selling industry due to economic headwinds and price sensitivity.
• The company's gross margin of 81.1% is relatively high compared to some competitors, indicating strong pricing power and efficient production.
• The reiteration of the full-year outlook suggests confidence in the company's ability to navigate the current challenges, although the expected slowdown in Q2 indicates a cautious approach.

Stakeholder Impact

• Shareholders may be concerned about the decrease in sales and earnings, but reassured by the strong performance in China and the reiteration of the full-year outlook.
• Associates in China may be encouraged by the strong growth in that market, while those in other regions may face challenges due to economic headwinds.
• Customers may be impacted by price increases and the availability of products in different markets.
• Employees may be affected by the company's performance and any changes in strategy.

Next Steps

• The company will continue to engage with Associate leaders to support business expansion.
• USANA plans to offer enhanced, market-specific incentive offerings to reward growth.
• The company will focus on growing its sales and customer base in India.
• USANA will pursue product innovation and development.
• The company will pursue additional acquisition opportunities.
• USANA's management team will hold a conference call and webcast to discuss the results on May 1, 2024.

Key Dates

Keywords

USANA, Health Sciences, Direct Selling, Nutritional Supplements, Q1 2024, Financial Results, Net Sales, EPS, China, Active Customers, Inflation, Share Repurchase